Recombinant Fc-fusion Cd137l protein activated the T-cells in vitro, and this data implies that direct CD137L signalling can mediate the osteosarcoma microenvironment and exert an anti-tumour immune effect through the activation of T cells. The gene discussed is TNFSF9; the disease is neoplasm.